PRTN3 and rheumatoid arthritis: Of these RA patients, 53.8% (7/13) were seropositive for both ACPA and RF, 7.7% (1/13) were either positive for ACPA or RF and 15.4% (2/13) were negative for both ACPA and/or RF.